Amedica to Report First Quarter 2014 Financial Results
GlobeNewswire - Wed May 07, 12:00PM CDT
Earnings Release Scheduled for May 15, 2014 After Market Close
Amedica to Present at the 13th Annual Needham Healthcare Conference
GlobeNewswire - Fri Apr 04, 8:15AM CDT
Amedica (Nasdaq:AMDA) announced today that it has been invited to present at the 13th Annual Needham Healthcare Conference, being held at the Westin Grand Central Hotel on April 8th and 9th in New York City.
Amedica Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 31, 3:37PM CDT
-- Fourth Quarter 2013 Total Revenue was $5.7 Million, an Increase of 8% Compared with $5.3 Million in Third Quarter 2013
Nasdaq stocks posting largest percentage increases
AP - Mon Mar 24, 2:40PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Amedica Corporation Announces Pricing of Initial Public Offering
GlobeNewswire - Thu Feb 13, 5:00AM CST
Amedica Corporation (Nasdaq:AMDA) today announced the pricing of its initial public offering of 3,500,000 shares of common stock at a public offering price of $5.75 per share. In addition, Amedica has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock from Amedica at the public offering price, less underwriting discounts. The offering is expected to close on February 19, 2014, subject to customary closing conditions. Amedica's common stock has been approved for listing on the NASDAQ Capital Market and is expected to begin trading under the ticker symbol "AMDA" on February 13, 2014.
Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace
PR Newswire - Tue May 21, 8:37AM CDT
Armada Health Care (Armada) is pleased to announce the launch of the new Armada corporate website (www.armadahealthcare.com). This new website was designed to clearly communicate Armada's unique and first-to-market services and its position as the leading health care service company focused on the specialty pharmacy industry.